# Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$153M |
| 2024 | -$315M |
| 2023 | $39M |
| 2022 | -$201M |
| 2021 | -$83M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-09-30 | -$36M |
| 2025-06-30 | -$43M |
| 2025-03-31 | -$38M |
| 2024-09-30 | -$76M |
| 2024-06-30 | -$76M |
| 2024-03-31 | -$122M |
| 2023-09-30 | $19M |
| 2023-06-30 | $20M |
| 2023-03-31 | -$2M |
| 2022-09-30 | -$55M |
| 2021-09-30 | -$23M |

Source: [CompaniesByCap](https://companiesbycap.com/company/AMLX/operating-income)